Robotti Robert Has Lifted Lsb Inds (LXU) Stake; PLANDAI BIOTECHNOLOGY (PLPL) Shorts Increased By 3615.38%

February 27, 2018 - By Adrian Mccoy

PLANDAI BIOTECHNOLOGY INC (OTCMKTS:PLPL) had an increase of 3615.38% in short interest. PLPL’s SI was 48,300 shares in February as released by FINRA. Its up 3615.38% from 1,300 shares previously. The SI to PLANDAI BIOTECHNOLOGY INC’s float is 0.03%. The stock decreased 30.82% or $0.005 during the last trading session, reaching $0.011. About 1.07M shares traded. Plandaí Biotechnology, Inc. (OTCMKTS:PLPL) has 0.00% since February 27, 2017 and is . It has underperformed by 16.70% the S&P500.

Robotti Robert increased Lsb Inds Inc (LXU) stake by 2.89% reported in 2017Q3 SEC filing. Robotti Robert acquired 63,741 shares as Lsb Inds Inc (LXU)’s stock declined 7.91%. The Robotti Robert holds 2.27M shares with $17.99 million value, up from 2.20M last quarter. Lsb Inds Inc now has $237.47 million valuation. The stock increased 17.09% or $1.22 during the last trading session, reaching $8.36. About 348,328 shares traded or 82.03% up from the average. LSB Industries, Inc. (NYSE:LXU) has declined 34.80% since February 27, 2017 and is downtrending. It has underperformed by 51.50% the S&P500.

Among 3 analysts covering LSB Industries (NYSE:LXU), 2 have Buy rating, 1 Sell and 0 Hold. Therefore 67% are positive. LSB Industries had 4 analyst reports since August 13, 2015 according to SRatingsIntel. On Thursday, August 13 the stock rating was downgraded by Zacks to “Hold”. The firm has “Strong Sell” rating given on Thursday, May 25 by ValuEngine. Feltl & Co upgraded LSB Industries, Inc. (NYSE:LXU) on Wednesday, March 2 to “Buy” rating. Avondale maintained LSB Industries, Inc. (NYSE:LXU) rating on Wednesday, March 9. Avondale has “Market Outperform” rating and $13 target.

Investors sentiment decreased to 1.18 in Q3 2017. Its down 0.35, from 1.53 in 2017Q2. It worsened, as 11 investors sold LXU shares while 28 reduced holdings. 17 funds opened positions while 29 raised stakes. 17.99 million shares or 4.30% less from 18.79 million shares in 2017Q2 were reported. Barrow Hanley Mewhinney Strauss Ltd Liability Company has invested 0% of its portfolio in LSB Industries, Inc. (NYSE:LXU). Neuberger Berman Ltd Liability Com accumulated 10,006 shares. Alliancebernstein LP invested 0% of its portfolio in LSB Industries, Inc. (NYSE:LXU). Oakworth holds 0% of its portfolio in LSB Industries, Inc. (NYSE:LXU) for 15 shares. 19,054 are owned by Royal Savings Bank Of Canada. Parametric Assocs Limited Liability Co owns 413,458 shares. Citadel Advisors Ltd holds 0% or 19,814 shares in its portfolio. Wells Fargo & Mn has invested 0% of its portfolio in LSB Industries, Inc. (NYSE:LXU). Atwood And Palmer invested in 650 shares or 0% of the stock. Tiaa Cref Inv Management Ltd Liability Com holds 60,072 shares. Blackrock owns 0% invested in LSB Industries, Inc. (NYSE:LXU) for 2.56 million shares. Trexquant Invest Limited Partnership reported 14,516 shares stake. Moreover, Parkside Retail Bank And Trust has 0% invested in LSB Industries, Inc. (NYSE:LXU). Goldman Sachs Grp stated it has 0% of its portfolio in LSB Industries, Inc. (NYSE:LXU). Thrivent Fincl For Lutherans has 0% invested in LSB Industries, Inc. (NYSE:LXU).

Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. The company has market cap of $2.05 million. It is developing Phytofare Catechin Complex, a botanical extract derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, Artemisia, and cannabis. It currently has negative earnings. The firm also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa.